For the first time, advertisements for one brand of snus can say that using the smokeless tobacco product "instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis."
Vaping helped 50,000 to 70,000 smokers in England quit smoking in 2017, new research estimates. But different policies and cultures around e-cigarettes mean those results might not be replicated elsewhere.
First there was pizza rat.
Of all the pre-teen related parental worries I have about my seventh grade daughter, at the top of my list right now is making sure she doesn't vape.
Vaping is in crisis. Smoking is taboo. Altria has a solution: Iqos, an electronic cigarette-like gadget that heats, but doesn't burn tobacco.
Altria's big investment in Juul isn't looking so hot now amid growing concerns about health risks tied to vaping and a broad regulatory crackdown on e-cigarettes. But the tobacco giant is unlikely to give up on Juul anytime soon.
Tobacco giants Altria and Philip Morris, which were once one company, have ended their discussions to reunite in a colossal merger that could have been worth more than $200 billion.
The CEO of Juul is out, as a growing number of vaping-related deaths and threats of federal regulation present a monumental challenge for the e-cigarette company.
Massachusetts Gov. Charlie Baker has called for a temporary statewide ban on the sale of all e-cigarettes and vaping products in response to a nationwide outbreak of lung injuries associated with vaping.
The great "vapocalypse" has begun and the horsemen leading the charge are from New York and Michigan.
